₹3746.8
Overview of Divis Laboratories Ltd
Divis Laboratories Ltd saw a rise in stock prices, with the company emerging as one of the top gainers on the Nifty index.
Vaishali Recommends Buying Divi's Laboratories - 13 Sep, 2023
An analyst recommends buying Divi's Laboratories stock at ₹3,787 with a stoploss of ₹3,700 and a target price of ₹3,900.
Divis Labs Shows Positive Trend; Major Gainer on Nifty50 - 12 Sep, 2023
Divi's Laboratories Ltd showed a positive trend with support at ₹3700. It was among the major gainers on Nifty50.
Divi's Labs Shares Trade at 49% Discount to Historical PE - 07 Sep, 2023
Shares of Divis Laboratories Ltd are trading at a significant discount to their historical price-to-earnings ratio, but the stock's average target price suggests a potential downside of 10%.
Divis Laboratories Among Top Gainers on Nifty 50 - 06 Sep, 2023
Shares of Divi's Labs emerged as one of the top gainers on the Nifty 50, contributing to a rise in the Nifty Pharma index by around 1%.
Divi's Labs Among Top Laggards in Stock Market - 01 Sep, 2023
Divis Laboratories Ltd was among the top laggards in the stock market as investors booked partial profits off pharma names. The Nifty Pharma also fell due to this trend.
Mixed Day for Divi's Laboratories Stock - 24 Aug, 2023
Divi's Laboratories had a mixed day in the stock market as shares remained flat over the last month. Sukhani advised traders to buy the stock with a stop loss of Rs 3,600.
Divi's Labs Among Top Gainers in Nifty 50 - 23 Aug, 2023
Divi's Laboratories Ltd gained up to 1.55% and was among the top gainers of Nifty 50 along with other companies like L&T, LTI Mindtree and Cipla.
Mixed Sentiments for Divis Laboratories Ltd. - 22 Aug, 2023
Prabhudas Lilladher is bullish on Divi's Labs in the short term, but also introduced Sell Ideas. They recommend a stock-specific approach and avoiding sectors with weak fundamentals.
Divi's Laboratories Misses 1QFY24 Estimates, Earnings Reduced - 21 Aug, 2023
Divi's Laboratories missed 1QFY24 estimates due to lower sales in generics and custom synthesis. EBITDA margin expanded sequentially owing to cost management activities. Earnings for FY24/FY25 reduced by 3%/5%. Neutral rating maintained as valuation factors in earnings upside over the next two years.
Divi's Labs Stock Falls Over Sales Miss and Expensive Valuations - 17 Aug, 2023
Divi's Laboratories Ltd's Q1FY24 EBITDA was 12% below Prabhudas Lilladher's estimate led by lower revenues across segments. They have downgraded the stock to 'Reduce' from 'Hold' rating with a revised target price of Rs3,000/share. The stock has fallen over 5.3% in the last six trading sessions.
Mixed Day for Divis Laboratories Ltd - 16 Aug, 2023
Divi's Laboratories' Q1 net profit declined 49.3% YoY to Rs 356 crore, missing estimates. However, the company has been identified as a global cost champion for several molecules.
Divi's Labs Reports Disappointing Q1 Results - 14 Aug, 2023
Divi's Laboratories Ltd's Q1 profit fell by half, missing estimates due to pricing pressures. Despite this, the stock gained 1.87%. Technical analysis recommends a short Iron Condor strategy.
Divi's Labs Faces Weak Q1 Performance Expectations - 11 Aug, 2023
Divis Laboratories Ltd faces expectations of a weak Q1 performance due to high base and margin pressure, resulting in estimated net profit fall of 42.6% YoY.
Divi's Laboratories Ltd Experiences Shift in Market Sentiment - 10 Aug, 2023
The crossing of Divi's Laboratories Ltd's short-term and long-term moving averages signals a shift in market sentiment.
Divis Laboratories Stock Falls on Short Build-Up and Poor Performance - 09 Aug, 2023
Divis Laboratories Ltd's stock experienced a short build-up, resulting in it being one of the worst-performing stocks on the Nifty 50.
Positive Outlook for Divi's Laboratories Stock - 07 Aug, 2023
Experts recommend buying Divi's Laboratories with a stop loss of Rs 3,650 as the stock gains up to 2.87%. The company has shown positive growth potential.
Divi's Labs Among Top Gainers on Nifty 50 - 04 Aug, 2023
Divi's Laboratories Ltd was among the top gainers on Nifty 50 along with other companies such as Adani Enterprise, Adani Ports & Special Economic Zone, Eicher Motors, and Hindalco Industries. Additionally, Divi's Labs' trading P/E ratio is 54.15.
Divis Laboratories Gains on Nifty 50 Index - 03 Aug, 2023
Divis Laboratories Ltd showcases impressive market performance by surpassing its 20-day SMA and being recommended as a buy call by Sudarshan Sukhani.
Divis Laboratories Ends in Green Despite Market Fall - 02 Aug, 2023
Despite a market fall, Divis Laboratories Ltd managed to end in the green and was among the top gainers on the Nifty 50. A sell call was made earlier in the day.
Source: S&P Global Market Intelligence
0.37%
Downside
Day's Volatility:1.74%
Upside
1.37%
27.14%
Downside
52 Weeks Volatility:32.15%
Upside
5.01%
Returns % | |
1 Month Return | 3.12 % |
3 Month Return | 7.69 % |
1 Year Return | 5.76 % |
Market Stats | |
Previous Close | ₹3,779.60 |
Open | ₹3,775.55 |
Volume | 2.62L |
Market Cap | ₹1,00,336.50Cr |
Organisation | Divis Laboratories Ltd |
Headquarters | Hyderabad |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Fundamentals of Divis Laboratories Ltd
Mutual Funds have increased holdings from 13.15% to 13.20% in Jun 2023 quarter
Netprofit is up for the last 2 quarters, 306.8 Cr → 320.97 Cr (in ₹), with an average increase of 4.4% per quarter
Foreign Institutions have increased holdings from 14.68% to 14.70% in Jun 2023 quarter
Revenue is up for the last 2 quarters, 1.82K Cr → 2.01K Cr (in ₹), with an average increase of 9.7% per quarter
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 129.0% return, outperforming this stock by 109.3%
In the last 1 year, Dr Reddys Laboratories Ltd has given 35.2% return, outperforming this stock by 29.5%
Retail Investor have decreased holdings from 12.31% to 12.14% in Jun 2023 quarter
In the last 7 days, DIVISLAB stock has moved down by -1.0%
Promoters have decreased holdings from 51.94% to 51.93% in Jun 2023 quarter
Divis Laboratories Ltd in the last 5 years
Lowest (28.97x)
November 21, 2022
Industry (48.78x)
September 20, 2023
Today (67.91x)
September 20, 2023
Highest (70.26x)
August 7, 2023
Funds | Holdings |
![]() | 3.82% |
![]() | 4.99% |
![]() | 4.37% |
![]() | 2.57% |
![]() | 5.54% |
Investors | Holdings % | Prev. 2 periods | 3M change |
---|---|---|---|
Promoter Holdings | 51.93% | ||
Foreign Institutions | 14.7% | 0.16 | |
Mutual Funds | 13.2% | 0.37 | |
Retail Investors | 12.14% | ||
Others | 8.04% | 1.43 |
Technicals of Divis Laboratories Ltd
News & Events of Divis Laboratories Ltd
News
Bajaj Auto New Products FY24 - Pulsar, Chetak & CNG Bike! The Indian Automaker Is Expected To Launch All New Products Soon... Read more
20 Sep, 2023 03:00 PMWill there also be a CNG scooter? Here’s what Rajiv Bajaj had to say... Read more
20 Sep, 2023 05:31 PMBajaj Auto stock price went up today, 21 Sep 2023, by 0.18 %. The stock closed at 5177.15 per share. The stock is currently trading at 5186.65 per share. Invest... Read more
21 Sep, 2023 08:07 AMDivis Laboratories Ltd(DIVISLAB | Price |
---|---|
52 Week High | ₹3934.7 |
52 Week Low | ₹2730 |
Divis Laboratories Ltd(DIVISLAB | Returns |
---|---|
1 Day Returns | -32.8% |
1 Month Returns | 3.12% |
3 Month Returns | 7.69% |
1 Year Returns | 5.76% |